130 related articles for article (PubMed ID: 19201825)
1. Synthetic peptides representing the N-terminal segment of surfactant protein C modulate LPS-stimulated TNF-alpha production by macrophages.
Garcia-Verdugo I; Garcia de Paco E; Espinassous Q; Gonzalez-Horta A; Synguelakis M; Kanellopoulos J; Rivas L; Chaby R; Perez-Gil J
Innate Immun; 2009 Feb; 15(1):53-62. PubMed ID: 19201825
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.
Sano H; Sohma H; Muta T; Nomura S; Voelker DR; Kuroki Y
J Immunol; 1999 Jul; 163(1):387-95. PubMed ID: 10384140
[TBL] [Abstract][Full Text] [Related]
3. Interactions between LPS and lung surfactant proteins.
Chaby R; Garcia-Verdugo I; Espinassous Q; Augusto LA
J Endotoxin Res; 2005; 11(3):181-5. PubMed ID: 15949147
[TBL] [Abstract][Full Text] [Related]
4. Protein-energy malnutrition decreases the expression of TLR-4/MD-2 and CD14 receptors in peritoneal macrophages and reduces the synthesis of TNF-alpha in response to lipopolysaccharide (LPS) in mice.
Fock RA; Vinolo MA; de Moura Sá Rocha V; de Sá Rocha LC; Borelli P
Cytokine; 2007 Nov; 40(2):105-14. PubMed ID: 17950615
[TBL] [Abstract][Full Text] [Related]
5. Cellular antiendotoxin activities of lung surfactant protein C in lipid vesicles.
Augusto LA; Synguelakis M; Espinassous Q; Lepoivre M; Johansson J; Chaby R
Am J Respir Crit Care Med; 2003 Aug; 168(3):335-41. PubMed ID: 12773323
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis lipoarabinomannan enhances LPS-induced TNF-α production and inhibits NO secretion by engaging scavenger receptors.
Józefowski S; Sobota A; Pawłowski A; Kwiatkowska K
Microb Pathog; 2011 Jun; 50(6):350-9. PubMed ID: 21419839
[TBL] [Abstract][Full Text] [Related]
7. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
[TBL] [Abstract][Full Text] [Related]
8. C-Mannosylated peptides derived from the thrombospondin type 1 repeat enhance lipopolysaccharide-induced signaling in macrophage-like RAW264.7 cells.
Muroi E; Manabe S; Ikezaki M; Urata Y; Sato S; Kondo T; Ito Y; Ihara Y
Glycobiology; 2007 Sep; 17(9):1015-28. PubMed ID: 17602137
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
[TBL] [Abstract][Full Text] [Related]
10. N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding.
Li J; Ikegami M; Na CL; Hamvas A; Espinassous Q; Chaby R; Nogee LM; Weaver TE; Johansson J
Biochemistry; 2004 Apr; 43(13):3891-8. PubMed ID: 15049696
[TBL] [Abstract][Full Text] [Related]
11. Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation.
Suzuki M; Tachibana I; Takeda Y; He P; Minami S; Iwasaki T; Kida H; Goya S; Kijima T; Yoshida M; Kumagai T; Osaki T; Kawase I
J Immunol; 2009 May; 182(10):6485-93. PubMed ID: 19414803
[TBL] [Abstract][Full Text] [Related]
12. Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein.
García-Verdugo I; Sánchez-Barbero F; Soldau K; Tobias PS; Casals C
Biochem J; 2005 Oct; 391(Pt 1):115-24. PubMed ID: 15932345
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of peritoneal macrophage functions in mice receiving lethal and non-lethal doses of LPS.
Víctor VM; De la Fuente M
J Endotoxin Res; 2000; 6(3):235-41. PubMed ID: 11052178
[TBL] [Abstract][Full Text] [Related]
14. Screening of mimetic peptides for CD14 binding site with LBP and antiendotoxin activity of mimetic peptide in vivo and in vitro.
Xu Z; Qian GS; Li Q; Feng QJ; Wu GM; Li KL
Inflamm Res; 2009 Jan; 58(1):45-53. PubMed ID: 19115038
[TBL] [Abstract][Full Text] [Related]
15. The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides.
David SA; Awasthi SK; Balaram P
J Endotoxin Res; 2000; 6(3):249-56. PubMed ID: 11052180
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.
Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O
J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844
[TBL] [Abstract][Full Text] [Related]
17. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.
Yibin G; Jiang Z; Hong Z; Gengfa L; Liangxi W; Guo W; Yongling L
Biochem Pharmacol; 2005 Jul; 70(2):209-19. PubMed ID: 15935330
[TBL] [Abstract][Full Text] [Related]
18. Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury.
Piao N; Ikejima K; Kon K; Aoyama T; Osada T; Takei Y; Sato N; Watanabe S
Life Sci; 2009 Oct; 85(17-18):617-24. PubMed ID: 19647752
[TBL] [Abstract][Full Text] [Related]
19. Propofol suppresses tumor necrosis factor-alpha biosynthesis in lipopolysaccharide-stimulated macrophages possibly through downregulation of nuclear factor-kappa B-mediated toll-like receptor 4 gene expression.
Wu GJ; Chen TL; Chang CC; Chen RM
Chem Biol Interact; 2009 Aug; 180(3):465-71. PubMed ID: 19433076
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide interactions of C-terminal peptides from human thrombin.
Singh S; Kalle M; Papareddy P; Schmidtchen A; Malmsten M
Biomacromolecules; 2013 May; 14(5):1482-92. PubMed ID: 23537377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
